The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Makrigiannis, A. P.
Right arrow Articles by Anderson, S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Makrigiannis, A. P.
Right arrow Articles by Anderson, S. K.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Substance via MeSH
The Journal of Immunology, 2001, 166: 5034-5043.
Copyright © 2001 by The American Association of Immunologists

Class I MHC-Binding Characteristics of the 129/J Ly49 Repertoire1

Andrew P. Makrigiannis*, Amanda T. Pau*, Ali Saleh*, Robin Winkler-Pickett*, John R. Ortaldo* and Stephen K. Anderson2,*,{dagger}

* Laboratory of Experimental Immunology, Division of Basic Sciences, and {dagger} Intramural Research Support Program, Science Applications International Corp. Frederick, National Cancer Institute, Frederick, MD 21702


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The Ly49 family of NK cell receptors and its MHC-binding characteristics have only been well characterized in C57BL/6 (B6) mice. Previous studies have shown that 129/J mice express unique Ly49 genes that are not found in the B6 strain. Screening of a 129/J cDNA library led to the discovery of 10 distinct full-length Ly49-related coding sequences (Ly49e, g, i, o, p, r, s, t, u, and v). Although 129/J mice share identical class I MHC (Kb and Db) transcripts with B6 mice, only one Ly49 is identical in the two strains (Ly49E). In addition to the previously characterized Ly49P, two new activating Ly49 proteins were discovered, Ly49R and U. The MHC specificity of the total 129/J Ly49 repertoire was evaluated with soluble class I MHC tetramers and found to be distinct compared with the B6 Ly49 repertoire. Ly49V bound to many types of class I MHC, suggesting that Ly49V+ NK cells may monitor host cells for a global down-regulation in MHC levels. An activating receptor, Ly49R, was shown to bind soluble class I molecules to a moderate degree, a result not previously observed for other activating Ly49 proteins. Furthermore, tetramer-binding results were confirmed functionally with cytotoxicity assays using sorted 129/J NK cells. This study shows that the Ly49 repertoire and its MHC-binding characteristics can be very different among inbred mouse strains. Ly49 divergence should be considered when using 129-derived embryonic stem cells for the production of gene-targeted mice, especially when an immune or NK-derived phenotype is under scrutiny.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Natural killer cells are an important component of the innate immune system, providing protection against intracellular infection and neoplasia through direct cytotoxic mechanisms and the secretion of cytokines (1). Efforts to identify receptors on NK cells that regulate cytotoxicity have yielded many interesting proteins. There are three major families of MHC-binding receptors on NK cells: killer cell Ig-like receptors (KIRs),3 and two lectin-like families, CD94/NKG2 and Ly49. KIR and Ly49 molecules have been found to bind class I MHC, and CD94/NKG2 heterodimers recognize the nonclassical MHC class I ligands HLA-E in humans and Qa-1 in mice (2). Although CD94/NKG2 are expressed in both species, KIRs are only expressed in humans and Ly49s only in rodents. Despite their lack of genetic homology, KIR and Ly49 function appears to have evolved in a convergent manner. KIR repertoires vary significantly between individuals such that different types and numbers of genes are expressed (3). Recently, the genomic sequence from two different KIR haplotypes was reported, and certain KIR genes are present or absent depending on the individual genotype (4). In contrast, little is known concerning Ly49 genotypic variation in rodents.

The Ly49 family represents a group of receptors expressed on murine NK, NK T cells, and some memory CD8+ T cells (5, 6, 7). The most extensively studied repertoire belongs to C57BL/6 (B6) mice. In these mice, Ly49AB6-JB6 are known to be expressed, whereas only gene fragments and/or aberrant mRNAs have been detected for Ly49kB6, lB6, mB6, and nB6 (5, 6, 8, 9, 10). We have previously shown that other mouse strains possess Ly49 molecules not found in B6 mice. Ly49O and P were found to be expressed in 129/J mice and Ly49L was found in CBA/J and C3H/He mice, yet none of these were detected in B6 mice using immunoprecipitation or RT-PCR (11, 12). This suggests that the Ly49 repertoire is extremely polymorphic between inbred mouse strains, even those sharing the same MHC haplotype such as 129/J and B6 (H-2b). In fact, Southern blotting with Ly49 single-exon probes has shown striking differences in the Ly49 gene content between mouse strains (9). A survey of inbred mouse strains with Ly49-specific Abs revealed that Ly49 epitope expression varies greatly. For example, a mAb that recognizes Ly49G2B6 (4D11) was found to stain DX5+CD3- NK cells from nine of nine strains tested, whereas 4E5 (Ly49DB6) stained NK cells from only three strains (B6, 129/J, and SJL) (13). Whether this is a result of allelic divergence or absent/silent genes is unknown.

With respect to function, Ly49 molecules can be grouped into activating and inhibitory subgroups. Inhibitory Ly49 sequences can be identified by the presence of an immunoreceptor tyrosine-based inhibitory motif (ITIM; I/VxYxxL/V) in the intracellular domain that recruits Src homology 2 domain-containing phosphatase 1 upon phosphorylation (14, 15). Activating Ly49 molecules (DB6, HB6, LCBA/J, and P129/J) lack an intact ITIM sequence but possess an arginine in the transmembrane domain for association with the signal-transducing protein DAP12 (16, 17). The binding of inhibitory Ly49 receptors to MHC ligands results in an inhibition of cytotoxicity (18, 19). In contrast, NK killing can be triggered via Ly49DB6 by H-2Dd-expressing target cells (20, 21). Furthermore, cross-linking of activating Ly49 molecules by specific Ab or MHC ligand results in cytokine production and intracellular calcium ion mobilization (11, 20, 22). In addition to Dd, Ly49D+ B6 NK cells have been shown to interact with Dr and Dsp2-expressing target cells (23). A recent report has shown that, like Ly49DB6, the presence of the nonobese diabetic allele of Ly49P on killer cells facilitates the lysis of Dd-expressing target cells (24).

Soluble MHC tetramers have been used to confirm and extend the known ligand specificities of many B6 Ly49 proteins. Some receptors, such as Ly49G2B6, show a very fine specificity toward Dd, whereas Ly49CB6 has a much broader range of tetramer binding (Kb, Db, Kd, Dd, and Dk), and no ligand has been found for Ly49EB6 or FB6 (19, 25, 26). Ly49AB6 was found to react with Dd and Dk tetramers and has been reported to inhibit NK lysis of Dd- and Dp-positive target cells (25, 26, 27). One report has also shown that Ly49AB6 is bound by Db tetramers (26). Although the role of inhibitory Ly49 such as Ly49CB6/IB6 can be explained as the monitoring of "self" in B6 mice, the purpose of inhibitory Ly49 that bind to MHC not present in B6 mice, as well as of activating Ly49 in general, still remains controversial.

Because 129 embryonic stem (ES) cells are used for the production of knockout mice for immunologic research, knowledge of the 129/J Ly49 repertoire is important, especially for studies dealing with NK biology. The 129/J and other closely related 129 strains show very different immunological phenotypes compared with B6 mice, with which they share the same MHC background. For example, 129/J mice are more susceptible to intracellular pathogens, such as the WA1 piroplasm and Sendai virus, than B6 mice (28, 29). Also, 129/J mice are more prone to the induction of autoimmune diseases such as experimental autoimmune encephalomyelitis and show greater disease severity in diabetes models than B6 mice (30, 31). In contrast, 129/J mice are relatively resistant to tumor induction by various carcinogenic agents and display a lower spontaneous overall tumor incidence (32, 33, 34). It has long been known that 129/J mice are not as capable as B6 mice in rejecting allogeneic and xenogeneic bone marrow transplants (35). Interestingly, the regulation of murine transplant rejection is at least partly dependent on Ly49 expression by NK cells (36). Our initial observations of the 129/J strain show that the Ly49 repertoire is different from B6 mice (11); therefore, elucidation of the total 129/J Ly49 repertoire was conducted to facilitate comparison of B6 and 129/J NK cell function. In addition, we have tested the ability of the newly described receptors to bind seven different types of class I MHC.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Mouse NK cells and tumor cell lines

B6 and 129/J mice were purchased from Jackson Laboratories (Bar Harbor, ME). All mice were kept under pathogen-free conditions until use at 20–25 wk of age. Liver NK cells were isolated as previously described (37). CD3-DX5+-sorted liver NK cells were expanded for 3–5 days in complete RPMI 1640 supplemented with 1000 Cetus U/ml IL-2 (Hoffman-LaRoche, Nutley, NJ). Routinely, 75–80% of the resulting cells were DX5+. Cell line 293T is a human kidney epithelial cell line. YB20 and YB/Dd rat cell lines were provided by Drs. J. Ryan and M. Nakamura (University of California Veterans Affairs Medical Center, San Francisco, CA).

Cloning of Ly49 cDNA from 129/J NK cells

A cDNA library from IL-2-activated 129/J liver NK cells was constructed in the pBK-CMV vector (Stratagene, La Jolla, CA) by Cell and Molecular Technologies (Phillipsburg, NJ). Library screening was conducted with Ly49eB6, dB6, g2B6, and o129/J probes (38). One hundred positive clones were analyzed, and the following Ly49 sequences were found: Ly49e129/J (AF247643), Ly49g1129/J (AF288375), Ly49g2129/J (AF288376), Ly49i129/J (AF237686), Ly49r129/J (AF288377), Ly49s129/J (AF288378), Ly49t129/J (AF288379), Ly49u129/J (AF288380), and Ly49v129/J (AF288381). Previously assigned GenBank files for Ly49p129/J and Ly49o129/J (AF146570 and AF146571, respectively) were updated to include 5' and 3' untranslated sequence identified in this study.

Plasmids and transfections

Ly49 cDNAs were PCR-subcloned into pEF6/V5-His (pEF6) using the TOPO TA Cloning Kit (Invitrogen, Carlsbad, CA). All subclones were sequenced. The day before transfection, 2.5 x 105 293T cells were seeded in six-well plates. The following day, 293T cells were transfected with FuGENE6 (Roche, Indianapolis, IN) using 1.25 µg each of the indicated combinations of Ly49/pEF6 and mDAP12/pSport (a gift from D. McVicar, National Cancer Institute, Frederick, MD) for activating receptors plus empty pEF6 vector to a total of 5 µg of DNA.

Abs and soluble class I MHC tetramers

The following mAbs were used for two-color flow cytometry: FITC-labeled 12A8, which binds to Ly49AB6/DB6 (39) and PE-labeled 4E5 (Ly49DB6) (16). YE1/48, YE1/32 (Ly49AB6) (40), 4D11 (Ly49G2B6) (19), 5E6 (Ly49CB6/IB6) (41), and A1 (Ly49AB6) (42) were all used as primary staining reagents followed by FITC-conjugated goat anti-rat IgG secondary (Kirkegaard & Perry Laboratories, Gaithersburg, MD) or, in the case of 5E6 and A1, FITC-conjugated goat anti-mouse IgG was used as a secondary (Kirkegaard & Perry Laboratories). A generous gift from V. Kumar, University of Chicago (Chicago, IL), 1F8 (Ly49CB6/IB6/HB6) was FITC-labeled, and PE-12A8 was also used for single-color analyses. Biotinylated 4G10 Ab, which recognizes phosphotyrosine, was purchased from Upstate Biotechnology (Lake Placid, NY). Detection of phosphorylated proteins was conducted as previously described (11). DX5 (pan-NK cell) mAb was a kind gift from L. Lanier (University of California at San Francisco). Dd expression was analyzed using FITC-conjugated 34-5-8S (BD PharMingen, San Diego, CA). Streptavidin-PE conjugated murine class I MHC tetramers Db, Dd, Dk, Ld, Kb, Kd, and Kk were provided by the National Institute of Allergy and Infectious Diseases Tetramer Facility/National Institutes of Health AIDS Research and Reference Reagent Program (Yerkes Regional Primate Research Center, Atlanta, GA). Tetramers were refolded in the presence of peptide previously shown to form a stable tetrameric structure and are as follows: Db, GP33–41 (KAVYNFATC) of lymphocytic choriomeningitis virus (43); Dd, GP160–169 (RGPGRAFVTI) of HIV-1 (44); Dk, MT389–397 (RRLGRTLLL) of polyoma virus (45); Kb, N324–332 (FAPGNYPAL) of sendai virus (46); Kd, NPP147–155 (TYQRTRALV) of influenza virus (47); Kk, Ha255–262 (FESTGNLI) of influenza virus (48); and Ld, NP118–126 (RPQASGVYM) of lymphocytic choriomeningitis virus (49). Class I MHC H chain and human {beta}2-microglobulin were both produced in bacteria using the pET expression system.

Flow cytometry and cytotoxicity assays

NK cells and transfected 293T were stained with the Abs described above (for 30 min on ice) and MHC tetramers (for 30 min on ice or at 37°C) and analyzed on a FACSort (BD Biosciences, Mountain View, CA). Incubations longer than 30 min did not increase tetramer-binding levels. NK cells used for cytotoxic analyses were sorted on a MoFlo (Cytomation, Ft. Collins, CO). Cytotoxicity assays were conducted as previously described (19).


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
mAb 4E5 detects activating and inhibitory Ly49 molecules in 129/J mice

We have previously observed that anti-Ly49 immunoprecipitates of 129/J NK cells yield different phosphotyrosine-banding patterns when compared with NK cells from B6 mice (11). Specifically, immunoprecipitation with mAb 4E5, which only binds the activating Ly49D receptor in the B6 strain, results in the coimmunoprecipitation of both activating and inhibitory Ly49 molecules in 129/J mice (11). To better characterize the Ly49DB6-like receptors in 129/J mice, two-color flow cytometric analysis was conducted with 4E5 and 12A8. A mAb that can bind to Ly49DB6 as well as Ly49AB6, 12A8 has been shown to react with a subpopulation of 129/J NK cells (13, 39). Two-color staining with 12A8 and 4E5 of B6 NK cells results in four populations, a double-negative, two double-positive, and a 4E5-12A8+ single-positive population (Fig. 1GoA). The single-positive population in the lower right quadrant represents Ly49A+D- NK cells, whereas the upper right quadrant contains Ly49A+D+ (12A8high) and Ly49A-D+ (12A8low) populations. In contrast, when the same Abs are used to stain 129/J NK cells, a very different pattern is observed (Fig. 1GoC). The 4E5-12A8+ population is not present, and instead a 4E5+12A8- population appears (upper left quadrant). Although there are still two double-positive populations in 129/J mice, the 12A8high population is gone, and instead a 4E5high population is now present. NK cells from a first generation cross of B6 and 129/J mice show that all populations of the parent mice are present, yet the single-positive populations are diminished (Fig. 1GoB).



View larger version (34K):
[in this window]
[in a new window]
 
FIGURE 1. A 4E5 vs 12A8 two-color histogram of liver NK cells. Three days after injection with IL-2, liver NK cells were isolated from (A) B6, (B) B6 x 129/J F1, and (C) 129/J mice; stained with PE-4E5 and FITC-12A8; and analyzed on a FACSort as described in Materials and Methods.

 
To determine the nature of the Ly49 molecules expressed by the sorted populations in Fig. 1GoC, proteins were isolated from pervanadate-treated NK cells, immunoprecipitated with Ly49-specific mAb, separated by SDS-PAGE under nonreducing conditions, and detected by anti-phosphotyrosine blotting. We have previously shown that this method will detect inhibitory Ly49 proteins as a ~110-kDa band due to a phosphorylated ITIM. In addition, a ~28-kDa band (DAP12) is coimmunoprecipitated from activating Ly49 molecules (22). Activating Ly49 receptors have no ITIM; therefore, they are not directly phosphorylated, and their presence is detected indirectly through DAP12 association. The results of two such experiments are shown in Fig. 2Go, A and B. Immunoprecipitation of unsorted B6 splenic NK cells with 4E5 only detected the DAP12 molecule associated with the activating receptor, Ly49D. In contrast to B6 mice, unsorted 129/J NK cells showed both activating and inhibitory receptors when immunoprecipitated with 4E5 as previously reported (11). Due to concerns that different organs might contain different NK populations, bulk spleen and liver 129/J NK cells were compared and shown to contain both types of 4E5-reactive receptors (Fig. 2GoA). The type of receptor represented in the sorted populations of Fig. 1GoC was then analyzed. The upper left quadrant containing 4E5+12A8- cells was found to contain only inhibitory-type receptors (Fig. 2GoA). This suggests that 129/J mice possess an inhibitory-type Ly49 that is recognized by 4E5 but not 12A8.



View larger version (40K):
[in this window]
[in a new window]
 
FIGURE 2. Immunoprecipitation and anti-phosphotyrosine blotting reveals 4E5+12A8+-activating and 4E5+12A8--inhibitory receptors in 129/J mice. A, Liver or splenic NK cells were isolated, sorted, expanded in IL-2-containing medium, and treated with pervanadate followed by immunoprecipitation with 4E5. Isolated proteins were then subjected to SDS-PAGE under nonreducing conditions, transferred, and immunoblotted with anti-phosphotyrosine. Molecular mass in kDa is shown on the left. B, 129/J NK cells were sorted for 4E5 and 12A8, pervanadate stimulated, followed by immunoprecipitation by 4E5 or 12A8 as indicated, and then analyzed as described above.

 
Immunoprecipitation with 4E5 of the 4E5+12A8+ populations (both 4E5-high and -low) resulted in the detection of both inhibitory and activating forms (Fig. 2GoA). The 4E5low12A8+ population was found to contain an activating receptor that was immunoprecipitated by both 4E5 and 12A8 (Fig. 2GoB). The appearance of a ~60-kDa band is not always reproducible, as noted by its absence in Fig. 2GoA, and is most likely an Ig H chain breakdown product. The 4E5high12A8+ population contained the 4E5/12A8-reactive activating receptor as well as a 4E5+12A8- inhibitory molecule (Fig. 2GoB), most probably the same one observed in the 4E5+12A8- population (Fig. 2GoA). These experiments suggest the existence of at least two different, independently expressed Ly49DB6-related molecules in 129/J mice. It appears that 12A8 only reacts with the activating receptor, whereas 4E5 reacts with both. The existence of a 4E5-reactive inhibitory receptor corroborates two-color flow cytometric analyses showing that 129/J, but not B6, mice contain a small but measurable population of 4E5+CD3+ T cells (data not shown). In B6 mice, expression of Ly49D is not detectable on T cells (50). The discovery that 4E5 recognizes an inhibitory Ly49 protein in 129/J mice supports observations that activating Ly49 receptors are not expressed on T cells.

The 129/J mice express at least 10 different Ly49-related genes

To further characterize the 129/J Ly49 repertoire, a cDNA library was constructed using mRNA from IL-2-activated 129/J liver NK cells. This library was then probed with Ly49eB6, dB6, g2B6, and o129/J full-length coding regions, and 100 positive clones were sequenced. A total of 10 distinct Ly49-related sequences were found. Table IGo shows the percentage of amino acid identity between the new 129/J Ly49 cDNAs and all known B6 Ly49 full-length coding regions. Only one sequence (Ly49e129/J) was found to be highly similar to a B6 Ly49 gene. Ly49e129/J contained only one silent nucleotide difference when compared with the Ly49eB6 nucleotide-coding region. Both Ly49g1 and g2 isoforms were found in 129/J NK cells, with the Ly49g1 insert sharing 37/39 nucleotides between the 129/J and B6 alleles (data not shown).


View this table:
[in this window]
[in a new window]
 
Table I. Comparison of amino acid identity of 129/J and B6 Ly49 repertoires1

 
Five new Ly49 cDNA sequences were discovered and have been named Ly49r–v129/J. Based on a previous survey of Ly49 alleles, a boundary was set of at least 95% identity at the protein level for sequences to be considered as potential alleles (51). Until allelic variants are verified by genomic mapping, these new designations should be considered tentative. The predicted amino acid sequences of the novel Ly49 receptors is provided in Fig. 3Go. Ly49R129/J and U129/J are putative activating receptors that lack an ITIM domain and contain a transmembrane arginine residue (Fig. 3Go). Ly49R129/J and U129/J are most similar to Ly49DB6 and HB6, respectively, whereas the inhibitory Ly49S129/J and V129/J are most similar to Ly49FB6 and AB6, respectively (Table IGo). Ly49T129/J is distantly related to Ly49G2B6.



View larger version (43K):
[in this window]
[in a new window]
 
FIGURE 3. Alignment of novel 129/J Ly49 predicted amino acid sequences. The amino acid translation of the newly described 129/J Ly49 cDNA coding regions is provided. Dashes indicate identity, and periods indicate sequence gaps. The transmembrane domain is underlined. The putative ITIM domain (I/VxYxxV/L) is boxed, as is the location of the arginine (R) residue required for DAP12 association by activating Ly49 receptors. GenBank accession numbers are provided in Materials and Methods.

 
The MHC genotype of 129/J mice was assessed by RT-PCR cloning using B6-derived primers for Kb and Db transcripts followed by sequencing. We found that the 129/J alleles for Kb and Db are identical with their B6 counterparts over the full coding region at the nucleotide level, suggesting that Ly49 divergence is not a consequence of MHC coevolution (data not shown).

Reactivity of 129-Ly49 proteins to Ly49-specific mAb

To identify the molecules responsible for the staining and biochemical patterns observed in Figs. 1Go and 2Go, expression constructs were transiently transfected into 293T cells and stained with a panel of Ly49-specific mAb. Three receptors, Ly49O129/J, R129/J, and V129/J, were found to react strongly with 4E5 and/or 12A8 (Fig. 4Go and Table IIGo). As predicted by the biochemical data (Fig. 2GoB), the putative activating Ly49R129/J was bound by both 4E5 and 12A8, whereas the two putative inhibitory receptors, Ly49O129/J and V129/J, were recognized by only 4E5 and not 12A8 (Fig. 4Go). This contrasts with our previous finding that Ly49O129/J did not bind to 4E5 (11). This discrepancy was resolved by sequencing of the PCR-derived Ly49o129/J expression construct, which was found to have a frameshift mutation. These staining results, along with the immunoprecipitation data, suggest that the 4E5+12A8- population contains NK cells expressing Ly49O129/J and/or V129/J but not Ly49R129/J. The 4E5high12A8+ population coexpresses Ly49O129/J and/or V129/J and Ly49R129/J. Finally, the 4E5low12A8+-activating population is due to the singular expression of Ly49R129/J (Fig. 1GoC).



View larger version (42K):
[in this window]
[in a new window]
 
FIGURE 4. Differential binding of 4E5 and 12A8 to Ly49R129/J, O129/J, and V129/J. The 293T cells were transiently transfected with Ly49R129/J, O129/J, and V129/J expression constructs using the FuGENE6 lipid transfection reagent. Ly49R129/J was also cotransfected with mDAP12 expression vector. After 1 day, transfected cells were stained with PE-12A8 or PE-4E5 and analyzed on a FACSort. This figure is representative of four similar experiments.

 

View this table:
[in this window]
[in a new window]
 
Table II. Relative binding of Ly49-specific mAb to 129/J Ly49 receptors1

 
With the exception of Ly49S129/J, all other 129/J Ly49 receptors were found to react with at least one and, in some cases, multiple (Table IIGo). For example, 4D11 was found to bind to 129/J, Ly49G2129/J, and Ly49T129/J. YE1/48 showed weak reactivity with Ly49P129/J, V129/J, T129/J, and R129/J. YE1/32 produced a reactivity pattern similar to YE1/48 but of lesser intensity. A1, which has been shown to bind Ly49AB6 and Ly49PNOD (24, 52), was also found to react with Ly49P129/J. A newly developed mAb, 1F8, which binds to Ly49CB6, IB6, and HB6 was found to react well with Ly49I129/J and, to a slightly lesser extent, Ly49U129/J. As expected, mAb 5E6 did not bind to any 129/J Ly49 molecules. This Ab was produced in the 129/J strain and was previously shown not to bind 129/J NK cells to any detectable degree (13, 53).

Soluble murine MHC class I tetramers reveal ligand specificities of the 129/J Ly49 repertoire

Fluorochrome-labeled soluble murine class I MHC "tetramers" have previously been used to identify the specificity of various members of the B6 Ly49 repertoire (25, 26). Therefore, to investigate the MHC-binding characteristics of the 129/J Ly49 repertoire, the tetramer approach was used. To determine the level of expression, 293T cells transfected with individual Ly49 expression constructs were stained with specific mAb or PE-conjugated murine class I tetramers Db, Dd, Dk, Kb, Kd, Kk, and Ld (Fig. 5Go). No control staining for Ly49S129/J expression is shown, due to a lack of Ly49S-reactive Abs (Table IIGo). Otherwise, all transfected cells showed relatively high levels of appropriate Ly49 expression (Fig. 5Go). Observed differences in expression levels of individual receptors may be due to differences in detection (FITC- vs PE-labeling). Also, it cannot be assumed that the cross-reactive mAbs used all share similar affinities for the 129/J Ly49 proteins. As a control, tetramers were used to stain 293T cells transiently expressing Ly49AB6, CB6, and DB6. Tetramer binding to these three receptors was found to be almost identical with that reported previously (data not shown).



View larger version (53K):
[in this window]
[in a new window]
 
FIGURE 5. Binding of soluble murine MHC class I tetramers to 129/J Ly49-transfected 293T cells. The 129/J Ly49 cDNA/pEF6 expression vector constructs were transiently transfected into 293T cells and, the next day, were incubated on ice for 30 min with a specific mAb or PE-conjugated MHC tetramers. Cells were then washed and analyzed on a FACSort. Gray-filled curves represent staining of the mAb or tetramer of 293T cells transfected with "empty" pEF6 vector. Black-filled curves show the binding of Ly49/pEF6-transfected 293T cells.

 
The results of the tetramer binding analyses indicated that some Ly49 bound to many types of class I MHC, whereas others bound to a few or none. As previously reported for Ly49G2B6, Ly49G2129/J bound soluble Dd (Fig. 5Go) (25). Ly49G2129/J also bound to Dk and Kd, but to a lesser extent. Ly49O129/J, Ly49R129/J, and Ly49V129/J bound Dd and Dk. To our knowledge, this is the first report of a MHC tetramer binding to an activating receptor, Ly49R129/J. The tetramer binding by Ly49O129/J and V129/J was particularly strong, especially Ly49V129/J to Dk (Fig. 5Go). Surprisingly, Ly49O129/J and Ly49V129/J also showed strong reactivity to Ld (Fig. 5Go), something not seen with their closest inhibitory B6 counterpart, Ly49AB6, which was found to bind Dd and Dk (25, 26).

In addition to binding Dd, Dk, and Ld, Ly49V129/J also bound strongly to Db. The ability of Ly49V129/J and Ly49O129/J to bind the autologous Db haplotype suggests that they can detect the presence of self-MHC as shown for the related Ly49AB6. (26). Ly49V129/J showed weaker reactivity toward Kb, Kd, and Kk (Fig. 5Go). Ly49V129/J is reminiscent of Ly49CB6 in its ability to bind many types of murine class I MHC (25). Ly49S129/J, Ly49T129/J, and Ly49U129/J showed no significant binding to any MHC tetramers, whereas the third activator, Ly49P129/J, only showed a low level of binding to Dd (Fig. 5Go). Finally, Ly49I129/J-transfected 293T showed the second highest promiscuity with reactivity toward Dk, Kb, Kd, and Kk (Fig. 5Go). The MHC tetramer-binding data obtained for Ly49O129/J and V129/J from transiently transfected human cells was confirmed in stably transfected rat RNK-16 cells (data not shown).

The tetramer binding experiments described above were all conducted on ice. However, this may not reflect the binding potential of Ly49 and MHC proteins at physiological temperature. To test the temperature-dependency of tetramer binding, duplicate samples of Ly49-transfected 293T cells were incubated on ice or at 37°C and then analyzed by flow cytometry. Tetramer binding at 37°C increased over that seen on ice where it was already present and, in some cases, appeared where it was not observed on ice. There were notable increases in the binding of Db to Ly49G2129/J, O129/J, and R129/J (Table IIIGo). However, in the majority of cases where "cold" tetramer binding was not observed, there was no promiscuity induced at 37°C.


View this table:
[in this window]
[in a new window]
 
Table III. Temperature-dependent binding of soluble murine class I MHC to 129/J Ly49 receptors1

 
Temperature-dependent binding increases were seen by Ly49R129/J for Dd, Dk, and Ld (Table IIIGo). Because Ly49R129/J and Ly49DB6 are closely related, this prompted us to perform a similar experiment with Ly49DB6-transfected 293T. No binding of Ly49DB6-expressing 293T was found for any tetramers when incubated on ice as previously reported (24), but, at 37°C, the Dd, Dk, and Ld tetramers were bound (data not shown). This brings into question the ability of other activating Ly49 proteins to bind MHC tetramers at 37°C, but Ly49P129/J and U129/J did not show enhanced tetramer binding at the higher incubation temperature (Table IIIGo). Interestingly, there was no increase in tetramer binding to Ly49I129/J at 37°C over that already seen on ice. Also of interest was the significantly increased binding of the H-2b,d,k alleles of H-2K for Ly49V129/J (Table IIIGo). Incubation at physiological temperature shows significant binding of Ly49V129/J to all soluble class I MHC tetramers used in this study. This suggests that Ly49V+ 129/J NK cells monitor host cells for a global down-regulation of class I MHC.

Ly49O and/or V+ NK cell cytotoxicity is inhibited by class I MHC Dd

Identification of mAb that can bind to the novel 129/J Ly49 proteins allowed the possibility of isolating different NK subpopulations for functional analysis to confirm the observations of the tetramer-binding experiments. When transiently expressed in 293T or stably expressed in RNK-16, Ly49O129/J and V129/J induced binding of the Dd tetramer (Fig. 5Go and data not shown). Because both of these receptors are predicted to be inhibitory in nature, the Ly49O and/or V (hereafter referred to as Ly49O/V)-positive NK subset should be suppressed by Dd-expressing target cells. To test this hypothesis, 129/J NK cells were sorted into 4E5+12A8- (Ly49O/V-positive and Ly49R-negative), 4E5+12A8+ (Ly49O/V-positive and Ly49R-positive), and 4E5-12A8- (Ly49O and V-negative and Ly49R-negative) populations and used as effector cells against the BA/2-derived (H-2d) P815 target cell. The single- and double-positive populations, which contain Ly49O129/J and/or V129/J, lysed P815 poorly (Fig. 6GoB). In contrast, double-negative NK cells displayed a 4-fold increase in killing against this H-2d target cell (Fig. 6GoB). The classical NK target cell YAC-1 was used as a control for the cytotoxic potential of the differentially sorted populations. All three populations lysed YAC-1 cells efficiently at low E:T ratios in a fashion comparable to unsorted splenic B6 NK cells (Fig. 6GoA). This indicates that the 4E5-reactive subpopulation contains a receptor that can inhibit NK cytotoxicity in the presence of a H-2d-derived ligand.



View larger version (41K):
[in this window]
[in a new window]
 
FIGURE 6. Ly49O/V+ 129/J NK cell cytotoxicity is inhibited by Dd-bearing target cells. The 129/J NK cells were differentially sorted for 4E5 and 12A8, expanded in IL-2, and used as effector cells in a 4-h 51Cr-release assay against (A) YAC-1, (B) P815, (D) YB20, (E) YB/Dd, and (F) YB/Dd in the presence or absence of 4E5 F(ab')2. The data represent the mean of triplicate wells ± SD. C, YB20 (shown in gray) and YB/Dd (shown by the black histogram) were subjected to FACS analysis with FITC-conjugated 34-5-8S mAb.

 
To prove that class I was responsible for the observed inhibition, similar populations of 129/J NK cells were used as effectors against the rat myeloma YB20 and a stably transfected derivative, YB/Dd, expressing physiological levels of murine Dd (Fig. 6GoC). Both 4E5+12A8- (Ly49O/V-positive and R-negative) and 4E5-12A8- (Ly49O/V-negative and R-negative) NK cells displayed similar levels of cytotoxicity toward the YB20 parental line (Fig. 6GoD). In contrast, lysis by the 4E5+12A8- subpopulation was severely inhibited against the Dd-expressing YB20 transfectant in comparison to the lysis by the 4E5-12A8- subpopulation (Fig. 6GoE). This suggests that Dd is a ligand for Ly49O129/J and/or V129/J. Unsorted 129/J NK cells also displayed decreased cytotoxicity toward YB/Dd compared with the sorted 4E5-12A8- population (Fig. 6GoE). This is consistent with the expression of Ly49G, O, and V on unsorted 129/J NK cells, especially Ly49G129/J, which is an abundant 129/J receptor that can also bind the Dd tetramer (Fig. 5Go). Cytotoxicity and cytokine secretion of Ly49D+ B6 NK cells in response to Dd-expressing target cells can be blocked by preincubation with 4E5-F(ab')2 (20, 23). Because 4E5 also recognizes Ly49O129/J/V129/J, the inhibitory signal should also be affected by such treatment. Indeed, blockade with 4E5-F(ab')2 resulted in the restoration of cytotoxicity by the 4E5+12A8- population to levels obtained by the 4E5-12A8- population toward YB/Dd (Fig. 6GoF). We found that 4E5 F(ab')2 did not affect the lysis of YB/Dd induced by 4E5-12A8- cells. Collectively, these results indicate that Ly49O129/J and/or V129/J bind to murine class I Dd and signal in a manner which inhibits NK cell cytotoxicity.


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The order of all known B6 Ly49 genes was recently confirmed, along with the identification of a new Ly49d-like gene fragment (54). This fragment may represent the B6 allele of Ly49o, v, or r. In addition, we have isolated B6 genomic DNA fragments containing exon 7 of what may be the genes for Ly49vB6 and rB6 (S. K. Anderson, unpublished observations). However, this still leaves open the possibility that the majority of Ly49 cDNAs described in this study, with the exception of Ly49e129/J, are the products of 129/J-specific genes. There are some pairs that may represent alleles, for example, Ly49iB6/i129/J and gB6/g129/J. The order of 129/J Ly49 genes in the 129/J genome would shed light on whether some of the newly described genes are in fact alleles. Comparison of Ly49 cDNAs between various strains has shown that 99% nucleotide homology exists for several family members (51), suggesting that a very high level of amino acid homology (>98%) is indicative of true Ly49 alleles. Based on a low level of homology to their closest relative, Ly49p129/J, s129/J, t129/J, and v129/J are almost certainly new genes. We have found selective Ly49 gene expression in several mouse strains. For example, Ly49l transcripts were detected in CBA/J and C3H/He but not B6 NK cells, even though at least two exons of Ly49l have been found in this strain’s genome (9, 12). Therefore, it is possible that the Ly49p, s, t, and v genes are also present, but silent, in B6 mice.

The ITIM of Ly49T129/J (VTYSTM) is different from that of all other known inhibitory Ly49 proteins (VxYxxV) and is identical with the binding motif for phosphatidylinositol (PI)3-kinase (YxxM) (Fig. 3Go). To test for possible PI3-kinase recruitment, we pervanadate-treated L929-Ly49T129/J stable transfectants, immunoprecipitated with a pan-Ly49 antiserum, separated proteins by SDS-PAGE, and blotted with an anti-PI3 kinase (anti-p85 subunit) mAb. Although p85 was readily detectable in whole-cell lysate, there was no evidence of its existence in immunoprecipitated samples. We subsequently blotted with anti-phosphotyrosine and observed the phosphorylated form of Ly49T129/J (data not shown). Therefore, the ITIM of Ly49T129/J is phosphorylated but does not seem to associate with PI3-kinase.

Compared with the divergence of the other nine 129/J Ly49 genes, the conservation of Ly49e between B6 and 129/J is intriguing. The conservation may emphasize an important and perhaps separate function for this Ly49 gene. It is interesting to note that Ly49e transcripts, unlike Ly49a–d, g, and i, are readily detectable in B6 fetal thymic and liver NK preparations (55). The divergence of the other Ly49 genes between 129/J and B6 may reflect the fact that these strains are very distantly related, despite sharing the same MHC haplotype (56).

Interestingly, Ly49I129/J bound Kb tetramers, whereas Ly49V129/J, G2129/J, and O129/J recognized Db (Fig. 5Go and Table IIIGo). Both tetramers represent self-MHC Ags of 129/J mice. Ly49CB6 binds to both Kb and Db in B6 mice (25). In contrast, Ly49IB6 did not significantly bind to H-2b tetramers (25) but, when overexpressed as a transgene, inhibited the rejection of H-2b bone marrow transplants (57). These results show that both B6 and 129/J mice possess multiple inhibitory receptors for self-MHC Ags. However, it is clear that even at physiological temperatures there is wide variation in the binding of different Ly49 molecules for the same class I MHC (Table IIIGo). Such variation in binding ability may be a consequence of the peptide being presented, as in the case of Ly49IB6 (25), or even a result of the presence or absence of peptide altogether, as has recently been reported for Ly49CB6 (58).

The three activating Ly49 cDNA species, Ly49P, R, and U, expressed in 129/J mice did not bind the Kb tetramer, but Ly49R129/J was able to bind Db at 37°C (Fig. 5Go and Table IIIGo). Despite this apparent self-reactivity, Ly49R seems to be expressed at moderate levels on 129/J NK cells (see 4E5low12A8+ population in Fig. 1GoC). Therefore, to avoid autoreactivity, all Ly49R129/J-expressing NK cells must also possess one or more inhibitory receptors for self-MHC Ags, and, considering the wide array of such receptors as discussed above, this is likely the case. In contrast, no self-MHC class I binding was reported for Ly49DB6 (25). Although MHC-binding data for Ly49HB6 is unavailable, it is entirely possible that Ly49HB6 may bind to an H-2b ligand because the extracellular domain of Ly49HB6 is very close to that of Ly49CB6 and IB6 (51). Unlike the study by Hanke et al. (25), where no detectable tetramer binding was reported for Ly49DB6, we have found that Ly49R129/J bound weakly to Dd, Dk, and Ld on ice (Fig. 5Go and Table IIIGo). This suggests that the affinity of different activating receptors for MHC ligands may vary widely. It also appears that the tetramer binding by Ly49R129/J is not an anomaly, because we have found that the recently described activating receptor in CBA/J and C3H mice, Ly49L (12), also bound weakly to Dd tetramers (data not shown). The well-documented ability of Ly49D+ NK cells to confer rapid cytotoxicity and cytokine production in response to Dd-expressing target cells reveals that tetramer-binding data may actually understate the binding potential of Ly49 molecules for in vivo-expressed MHC (20, 21). The increased binding of Ly49R129/J to Dd, Dk, and Ld, as well as the additional binding to Db at 37°C (Table IIIGo), and our finding that Ly49DB6 binds to Dd at physiological temperatures supports this position (data not shown).

Recently, the crystal structure of Ly49AB6 bound to Dd was deduced by Tormo et al. and the sites of contact between the two proteins predicted (59). The Ly49AB6 residues required for site 1 interaction with Dd, predicted to be the trans binding site (between a ligand and receptor on different cells), are fairly well conserved in those 129/J Ly49 proteins that were found to interact with Dd tetramers. In this study, Ly49G2129/J, O, V, R, and, to a much lesser extent, P, were found to bind Dd (Fig. 5Go and Table IIIGo). Of the 12 Ly49AB6 residues thought to be used for Dd binding in trans, Ly49G2129/J has 7 of 12, Ly49O129/J has 10 of 12, Ly49V129/J has 9 of 12, Ly49R129/J has 10 of 12, and Ly49P129/J has in common 12 of 12. It is interesting to note that the lowest (but still detectable) Dd-tetramer binding was seen with Ly49P129/J, which had all the predicted trans binding sites in common with Ly49AB6, but the best binding was seen with Ly49V129/J, which had only 9 of 12 binding sites conserved. Also, Ly49G2129/J had the least number of residues in common with Ly49AB6 for Dd binding, 7 of 12, but also bound the Dd tetramer much better than Ly49P129/J (Fig. 5Go and Table IIIGo). Our study, like that of Tormo et al., used bacterially expressed MHC and the same peptide for presentation by Dd. This suggests that other as yet unidentified residues may be important for MHC binding by Ly49 proteins. Comparison of the predicted MHC-contacting residues of the two pan-MHC-binding proteins, Ly49CB6 and Ly49V129/J, showed that they agreed at only 1 of 12 trans residues, despite Ly49CB6 binding Dd tetramers very well (25). This suggests that the Ly49C-like family members use an altogether different combination of residues for MHC-binding compared with Ly49A-like family members.

ES cells of 129/SvJ origin are the most widely used in current mouse gene-mutation studies, although most of the functional assays used to characterize the mutant mice were developed in non-129 mouse strains. Because 24% of 212 129/SvJ genomic sequence markers differ from the consensus 129 genotype (60), 129/SvJ is considered to be "contaminated." We have found that 129/SvJ splenocytes express transcripts identical with Ly49r129/J, s129/J, and v129/J (data not shown). This agrees with the prediction that chromosome 6, where the Ly49 gene cluster resides, is of 129 origin in 129/SvJ (60). Our current findings suggest that an ES cell of 129 origin would not be the appropriate choice for deletion of a gene mapping near the Ly49 locus where the phenotype of interest is immunological in nature. Even with many backcrosses to the phenotypically important strain, closely linked genes may be carried over and affect data interpretation. The divergence of the Ly49 repertoire of 129 mice, and the strain in general (56), from B6 mice requires a careful assessment of the use of this strain for the production of gene-targeted mice as it pertains to immunological studies, especially to the field of NK biology. The results presented here indicate that NK cells expressing a 129/J NK complex would possess a vastly different Ly49 repertoire with associated differences in MHC specificity and responses to these ligands. We predict that other inbred mouse strains may possess similarly divergent Ly49-repertoires, which may affect their respective NK cell functions.


    Acknowledgments
 
We thank Jami Willette-Brown and Lynn Taylor for their expert technical assistance and Dan McVicar for helpful discussion and critical review of this manuscript.


    Footnotes
 
1 This project has been funded in whole or in part with Federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. NO1-CO-56000. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. Animal care was provided in accordance with the procedures outlined in A Guide for the Care and Use of Laboratory Animals (National Institutes of Health Publication No. 86-23, 1985). The publisher or recipient acknowledges the right of the U.S. Government to retain a nonexclusive, royalty-free license in and to any copyright covering this article. Back

2 Address correspondence and reprint requests to Dr. Stephen K. Anderson, Science Applications International Corp. Frederick, National Cancer Institute, Frederick Cancer Research and Development Center, Building 560, Room 31-93, Frederick, MD 21702-1201. Back

3 Abbreviations used in this paper: KIR, killer cell Ig-like receptor; B6, C57BL/6; ITIM, immunoreceptor tyrosine-based inhibitory motif; ES, embryonic stem; PI, phosphatidylinositol. Back

Received for publication November 30, 2000. Accepted for publication February 14, 2001.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Bancroft, G. J.. 1993. The role of natural killer cells in innate resistance to infection. Curr. Opin. Immunol. 5:503.[Medline]
  2. Lanier, L. L.. 1998. NK cell receptors. Annu. Rev. Immunol. 16:359.[Medline]
  3. Uhrberg, M., N. M. Valiante, B. P. Shum, H. G. Shilling, K. Lienert-Weidenbach, B. Corliss, D. Tyan, L. L. Lanier, P. Parham. 1997. Human diversity in killer cell inhibitory receptor genes. Immunity 7:753.[Medline]
  4. Wilson, M. J., M. Torkar, A. Haude, S. Milne, T. Jones, D. Sheer, S. Beck, J. Trowsdale. 2000. Plasticity in the organization and sequences of human KIR/ILT gene families. Proc. Natl. Acad. Sci. USA 97:4778.[Abstract/Free Full Text]
  5. Smith, H. R., F. M. Karlhofer, W. M. Yokoyama. 1994. Ly-49 multigene family expressed by IL-2-activated NK cells. J. Immunol. 153:1068.[Abstract]
  6. Brennan, J., D. Mager, W. Jefferies, F. Takei. 1994. Expression of different members of the Ly-49 gene family defines distinct natural killer cell subsets and cell adhesion properties. J. Exp. Med. 180:2287.[Abstract/Free Full Text]
  7. Coles, M. C., C. W. McMahon, H. Takizawa, D. H. Raulet. 2000. Memory CD8 T lymphocytes express inhibitory MHC-specific Ly49 receptors. Eur. J. Immunol. 30:236.[Medline]
  8. Brennan, J., S. Lemieux, J. D. Freeman, D. L. Mager, F. Takei. 1996. Heterogeneity among Ly-49C natural killer (NK) cells: characterization of highly related receptors with differing functions and expression patterns. J. Exp. Med. 184:2085.[Abstract/Free Full Text]
  9. McQueen, K. L., J. D. Freeman, F. Takei, D. L. Mager. 1998. Localization of five new Ly49 genes, including three closely related to Ly49c. Immunogenetics 48:174.[Medline]
  10. McQueen, K. L., S. Lohwasser, F. Takei, D. L. Mager. 1999. Expression analysis of new Ly49 genes: most transcripts of Ly49j lack the transmembrane domain. Immunogenetics 49:685.[Medline]
  11. Makrigiannis, A. P., P. Gosselin, L. H. Mason, L. S. Taylor, D. W. McVicar, J. R. Ortaldo, S. K. Anderson. 1999. Cloning and characterization of a novel activating Ly49 closely related to Ly49A. J. Immunol. 163:4931.[Abstract/Free Full Text]
  12. Makrigiannis, A. P., J. Etzler, R. Winkler-Pickett, A. Mason, J. R. Ortaldo, S. K. Anderson. 2000. Identification of the Ly49L protein: evidence for activating counterparts to inhibitory Ly49 proteins. J. Leukocyte Biol. 68:765.[Abstract/Free Full Text]
  13. Ortaldo, J. R., A. T. Mason, R. Winkler-Pickett, A. Raziuddin, W. J. Murphy, L. H. Mason. 1999. Ly-49 receptor expression and functional analysis in multiple mouse strains. J. Leukocyte Biol. 66:512.[Abstract]
  14. Mason, L. H., P. Gosselin, S. K. Anderson, W. E. Fogler, J. R. Ortaldo, D. W. McVicar. 1997. Differential tyrosine phosphorylation of inhibitory versus activating Ly-49 receptor proteins and their recruitment of SHP-1 phosphatase. J. Immunol. 159:4187.[Abstract]
  15. Nakamura, M. C., E. C. Niemi, M. J. Fisher, L. D. Shultz, W. E. Seaman, J. C. Ryan. 1997. Mouse Ly-49A interrupts early signaling events in natural killer cell cytotoxicity and functionally associates with the SHP-1 tyrosine phosphatase. J. Exp. Med. 185:673.[Abstract/Free Full Text]
  16. Mason, L. H., J. Willette-Brown, S. K. Anderson, P. Gosselin, E. W. Shores, P. E. Love, J. R. Ortaldo, D. W. McVicar. 1998. Characterization of an associated 16-kDa tyrosine phosphoprotein required for Ly-49D signal transduction. J. Immunol. 160:4148.[Abstract/Free Full Text]
  17. Smith, K. M., J. Wu, A. B. Bakker, J. H. Phillips, L. L. Lanier. 1998. Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors. J. Immunol. 161:7.[Abstract/Free Full Text]
  18. Karlhofer, F. M., R. K. Ribaudo, W. M. Yokoyama. 1992. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature 358:66.[Medline]
  19. Mason, L. H., J. R. Ortaldo, H. A. Young, V. Kumar, M. Bennett, S. K. Anderson. 1995. Cloning and functional characteristics of murine large granular lymphocyte-1: a member of the Ly-49 gene family (Ly-49G2). J. Exp. Med. 182:293.[Abstract/Free Full Text]
  20. Mason, L. H., J. Willette-Brown, A. T. Mason, D. McVicar, J. R. Ortaldo. 2000. Interaction of Ly-49D+ NK cells with H-2Dd target cells leads to Dap-12 phosphorylation and IFN-{gamma} secretion. J. Immunol. 164:603.[Abstract/Free Full Text]
  21. Nakamura, M. C., P. A. Linnemeyer, E. C. Niemi, L. H. Mason, J. R. Ortaldo, J. C. Ryan, W. E. Seaman. 1999. Mouse Ly-49D recognizes H-2Dd and activates natural killer cell cytotoxicity. J. Exp. Med. 189:493.[Abstract/Free Full Text]
  22. Gosselin, P., L. H. Mason, J. Willette-Brown, J. R. Ortaldo, D. W. McVicar, S. K. Anderson. 1999. Induction of DAP12 phosphorylation, calcium mobilization, and cytokine secretion by Ly49H. J. Leukocyte Biol. 66:165.[Abstract]
  23. George, T. C., L. H. Mason, J. R. Ortaldo, V. Kumar, M. Bennett. 1999. Positive recognition of MHC class I molecules by the Ly49D receptor of murine NK cells. J. Immunol. 162:2035.[Abstract/Free Full Text]
  24. Silver, E. T., D. E. Gong, C. S. Chang, A. Amrani, P. Santamaria, K. P. Kane. 2000. Ly-49P activates NK-mediated lysis by recognizing H-2Dd. J. Immunol. 165:1771.[Abstract/Free Full Text]
  25. Hanke, T., H. Takizawa, C. W. McMahon, D. H. Busch, E. G. Pamer, J. D. Miller, J. D. Altman, Y. Liu, D. Cado, F. A. Lemonnier, P. J. Bjorkman, D. H. Raulet. 1999. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity 11:67.[Medline]
  26. Michaelsson, J., A. Achour, M. Salcedo, A. Kase-Sjostrom, J. Sundback, R. A. Harris, K. Karre. 2000. Visualization of inhibitory Ly49 receptor specificity with soluble major histocompatibility complex class I tetramers. Eur. J. Immunol. 30:300.[Medline]
  27. Olsson-Alheim, M. Y., J. Sundback, K. Karre, C. L. Sentman. 1999. The MHC class I molecule H-2Dp inhibits murine NK cells via the inhibitory receptor Ly49A. J. Immunol. 162:7010.[Abstract/Free Full Text]
  28. Moro, M. H., C. S. David, J. M. Magera, P. J. Wettstein, S. W. Barthold, D. H. Persing. 1998. Differential effects of infection with a Babesia-like piroplasm, WA1, in inbred mice. Infect. Immun. 66:492.[Abstract/Free Full Text]
  29. Mo, X. Y., M. Sangster, S. Sarawar, C. Coleclough, P. C. Doherty. 1995. Differential antigen burden modulates the {gamma} interferon but not the immunoglobulin response in mice that vary in susceptibility to Sendai virus pneumonia. J. Virol. 69:5592.[Abstract]
  30. Fritz, R. B., M. L. Zhao. 1996. Active and passive experimental autoimmune encephalomyelitis in strain 129/J (H-2b) mice. J. Neurosci. Res. 45:471.[Medline]
  31. Leiter, E. H., D. L. Coleman, A. B. Eisenstein, I. Strack. 1980. A new mutation (db3J) at the diabetes locus in strain 129/J mice. I. Physiological and histological characterization. Diabetologia 19:58.[Medline]
  32. Mayer, A., F. Lilly, M. L. Duran-Reynals. 1980. Genetically dominant resistance in mice to 3-methylcholanthrene-induced lymphoma. Proc. Natl. Acad. Sci. USA 77:2960.[Abstract/Free Full Text]
  33. Diamond, L. E., J. W. Berman, A. Pellicer. 1987. Differential expression of surface markers on thymic lymphomas induced by two carcinogenic agents in different mouse strains. Cell. Immunol. 107:115.[Medline]
  34. Smith, G. S., R. L. Walford, M. R. Mickey. 1973. Lifespan and incidence of cancer and other diseases in selected long-lived inbred mice and their F 1 hybrids. J. Natl. Cancer Inst. 50:1195.
  35. Lotzova, E., K. A. Dicke, J. J. Trentin, M. T. Gallagher. 1977. Genetic control of bone marrow transplantation in irradiated mice: classification of mouse strains according to their responsiveness to bone marrow allografts and xenografts. Transplant. Proc. 9:289.[Medline]
  36. Raziuddin, A., D. L. Longo, L. Mason, J. R. Ortaldo, M. Bennett, W. J. Murphy. 1998. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets. J. Immunol. 160:87.[Abstract/Free Full Text]
  37. Watanabe, M., K. L. McCormick, K. Volker, J. R. Ortaldo, J. M. Wigginton, M. J. Brunda, R. H. Wiltrout, W. E. Fogler. 1997. Regulation of local host-mediated anti-tumor mechanisms by cytokines: direct and indirect effects on leukocyte recruitment and angiogenesis. Am. J. Pathol. 150:1869.[Abstract]
  38. Benton, W. D., R. W. Davis. 1977. Screening {lambda}gt recombinant clones by hybridization to single plaques in situ. Science 196:180.[Abstract/Free Full Text]
  39. Mason, L. H., S. K. Anderson, W. M. Yokoyama, H. R. Smith, R. Winkler-Pickett, J. R. Ortaldo. 1996. The Ly-49D receptor activates murine natural killer cells. J. Exp. Med. 184:2119.[Abstract/Free Full Text]
  40. Takei, F.. 1983. Two surface antigens expressed on proliferating mouse T lymphocytes defined by rat monoclonal antibodies. J. Immunol. 130:2794.[Abstract]
  41. Stoneman, E. R., M. Bennett, J. An, K. A. Chesnut, E. K. Wakeland, J. B. Scheerer, M. J. Siciliano, V. Kumar, P. A. Mathew. 1995. Cloning and characterization of 5E6 (Ly-49C), a receptor molecule expressed on a subset of murine natural killer cells. J. Exp. Med. 182:305.[Abstract/Free Full Text]
  42. Yokoyama, W. M., L. B. Jacobs, O. Kanagawa, E. M. Shevach, D. I. Cohen. 1989. A murine T lymphocyte antigen belongs to a supergene family of type II integral membrane proteins. J. Immunol. 143:1379.[Abstract]
  43. Hudrisier, D., M. B. Oldstone, J. E. Gairin. 1997. The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H- 2Db and H-2Kb molecules. Virology 234:62.[Medline]
  44. Shirai, M., C. D. Pendleton, J. A. Berzofsky. 1992. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules. J. Immunol. 148:1657.[Abstract]
  45. Lukacher, A. E., C. S. Wilson. 1998. Resistance to polyoma virus-induced tumors correlates with CTL recognition of an immunodominant H-2Dk-restricted epitope in the middle T protein. J. Immunol. 160:1724.[Abstract/Free Full Text]
  46. Schumacher, T. N., M. L. De Bruijn, L. N. Vernie, W. M. Kast, C. J. Melief, J. J. Neefjes, H. L. Ploegh. 1991. Peptide selection by MHC class I molecules. Nature 350:703.[Medline]
  47. Rammensee, H. G., T. Friede, S. Stevanoviic. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41:178.[Medline]
  48. Olsen, A. C., L. O. Pedersen, A. S. Hansen, M. H. Nissen, M. Olsen, P. R. Hansen, A. Holm, S. Buus. 1994. A quantitative assay to measure the interaction between immunogenic peptides and purified class I major histocompatibility complex molecules. Eur. J. Immunol. 24:385.[Medline]
  49. Schulz, M., P. Aichele, R. Schneider, T. H. Hansen, R. M. Zinkernagel, H. Hengartner. 1991. Major histocompatibility complex binding and T cell recognition of a viral nonapeptide containing a minimal tetrapeptide. Eur. J. Immunol. 21:1181.[Medline]
  50. Smith, H. R., H. H. Chuang, L. L. Wang, M. Salcedo, J. W. Heusel, W. M. Yokoyama. 2000. Nonstochastic coexpression of activation receptors on murine natural killer cells. J. Exp. Med. 191:1341.[Abstract/Free Full Text]
  51. Makrigiannis, A. P., S. K. Anderson. 2000. Ly49 gene expression in different inbred mouse strains. Immunol. Res. 21:39.[Medline]
  52. Takei, F., J. Brennan, D. L. Mager. 1997. The Ly-49 family: genes, proteins and recognition of class I MHC. Immunol. Rev. 155:67.[Medline]
  53. Sentman, C. L., Jr J. Hackett, V. Kumar, M. Bennett. 1989. Identification of a subset of murine natural killer cells that mediates rejection of Hh-1d but not Hh-1b bone marrow grafts. J. Exp. Med. 170:191.[Abstract/Free Full Text]
  54. Depatie, C., S. H. Lee, A. Stafford, P. Avner, A. Belouchi, P. Gros, S. M. Vidal. 2000. Sequence-ready BAC contig, physical, and transcriptional map of a 2-Mb region overlapping the mouse chromosome 6 host-resistance locus cmv1. Genomics 66:161.[Medline]
  55. Toomey, J. A., S. Shrestha, S. A. de la Rue, F. Gays, J. H. Robinson, Z. M. Chrzanowska-Lightowlers, C. G. Brooks. 1998. MHC class I expression protects target cells from lysis by Ly49- deficient fetal NK cells. Eur. J. Immunol. 28:47.[Medline]
  56. Schalkwyk, L. C., M. Jung, A. Daser, M. Weiher, J. Walter, H. Himmelbauer, H. Lehrach. 1999. Panel of microsatellite markers for whole-genome scans and radiation hybrid mapping and a mouse family tree. Genome Res. 9:878.[Abstract/Free Full Text]
  57. Liu, J., M. A. Morris, P. Nguyen, T. C. George, E. Koulich, W. C. Lai, J. D. Schatzle, V. Kumar, M. Bennett. 2000. Ly49I NK cell receptor transgene inhibition of rejection of H2b mouse bone marrow transplants. J. Immunol. 164:1793.[Abstract/Free Full Text]
  58. Su, R. C., S. K. Kung, E. T. Silver, S. Lemieux, K. P. Kane, R. G. Miller. 1999. Ly-49CB6 NK inhibitory receptor recognizes peptide-receptive H-2Kb. J. Immunol. 163:5319.[Abstract/Free Full Text]
  59. Tormo, J., K. Natarajan, D. H. Margulies, R. A. Mariuzza. 1999. Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand. Nature 402:623.[Medline]
  60. Threadgill, D. W., D. Yee, A. Matin, J. H. Nadeau, T. Magnuson. 1997. Genealogy of the 129 inbred strains: 129/SvJ is a contaminated inbred strain. Mamm. Genome 8:390.[Medline]



This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
A. Rouhi, C. B. Lai, T. P. Cheng, F. Takei, W. M. Yokoyama, and D. L. Mager
Evidence for high bi-allelic expression of activating Ly49 receptors
Nucleic Acids Res., September 1, 2009; 37(16): 5331 - 5342.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. Xie, M. D. Stadnisky, and M. G. Brown
MHC Class I Dk Locus and Ly49G2+ NK Cells Confer H-2k Resistance to Murine Cytomegalovirus
J. Immunol., June 1, 2009; 182(11): 7163 - 7171.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
L.-H. Tai, M.-L. Goulet, S. Belanger, N. Toyama-Sorimachi, N. Fodil-Cornu, S. M. Vidal, A. D. Troke, D. W. McVicar, and A. P. Makrigiannis
Positive regulation of plasmacytoid dendritic cell function via Ly49Q recognition of class I MHC
J. Exp. Med., December 22, 2008; 205(13): 3187 - 3199.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
R. S. Goldszmid, A. Bafica, D. Jankovic, C. G. Feng, P. Caspar, R. Winkler-Pickett, G. Trinchieri, and A. Sher
TAP-1 indirectly regulates CD4+ T cell priming in Toxoplasma gondii infection by controlling NK cell IFN-{gamma} production
J. Exp. Med., October 29, 2007; 204(11): 2591 - 2602.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Pascal, N. R. Nathan, E. Claudio, U. Siebenlist, and S. K. Anderson
NF-{kappa}B p50/p65 Affects the Frequency of Ly49 Gene Expression by NK Cells
J. Immunol., August 1, 2007; 179(3): 1751 - 1759.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Kielczewska, H.-S. Kim, L. L. Lanier, N. Dimasi, and S. M. Vidal
Critical Residues at the Ly49 Natural Killer Receptor's Homodimer Interface Determine Functional Recognition of m157, a Mouse Cytomegalovirus MHC Class I-Like Protein
J. Immunol., January 1, 2007; 178(1): 369 - 377.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. H. Johansson, M. A. Taylor, M. Jagodic, K. Tus, J. D. Schatzle, E. K. Wakeland, and M. Bennett
Mapping of Quantitative Trait Loci Determining NK Cell-Mediated Resistance to MHC Class I-Deficient Bone Marrow Grafts in Perforin-Deficient Mice
J. Immunol., December 1, 2006; 177(11): 7923 - 7929.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. L. Rogers, A. Rouhi, F. Takei, and D. L. Mager
A Role for DNA Hypomethylation and Histone Acetylation in Maintaining Allele-Specific Expression of Mouse NKG2A in Developing and Mature NK Cells
J. Immunol., July 1, 2006; 177(1): 414 - 421.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. A. Benoit, J. Shannon, J. W. Chamberlain, and R. G. Miller
Influence of Xenogeneic {beta}2-Microglobulin on Functional Recognition of H-2Kb by the NK Cell Inhibitory Receptor Ly49C
J. Immunol., September 15, 2005; 175(6): 3542 - 3553.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Stevenaert, K. Van Beneden, V. De Colvenaer, A. S. Franki, V. Debacker, T. Boterberg, D. Deforce, K. Pfeffer, J. Plum, D. Elewaut, et al.
Ly49 and CD94/NKG2 receptor acquisition by NK cells does not require lymphotoxin-{beta} receptor expression
Blood, August 1, 2005; 106(3): 956 - 962.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
I. Bubic, M. Wagner, A. Krmpotic, T. Saulig, S. Kim, W. M. Yokoyama, S. Jonjic, and U. H. Koszinowski
Gain of Virulence Caused by Loss of a Gene in Murine Cytomegalovirus
J. Virol., July 15, 2004; 78(14): 7536 - 7544.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. P. Makrigiannis, E. Rousselle, and S. K. Anderson
Independent Control of Ly49g Alleles: Implications for NK Cell Repertoire Selection and Tumor Cell Killing
J. Immunol., February 1, 2004; 172(3): 1414 - 1425.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. J. Ma, E. T. Silver, B. Hazes, and K. P. Kane
Reciprocal Transfer of Class I MHC Allele Specificity between Activating Ly-49P and Ly-49W Receptors by Exchange of {beta}4-{beta}5 Loop Residues
J. Immunol., November 15, 2003; 171(10): 5337 - 5344.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. Voigt, C. A. Forbes, J. N. Tonkin, M. A. Degli-Esposti, H. R. C. Smith, W. M. Yokoyama, and A. A. Scalzo
Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells
PNAS, November 11, 2003; 100(23): 13483 - 13488.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. H. Mason, J. Willette-Brown, S. K. Anderson, W. G. Alvord, R. L. Klabansky, H. A. Young, and J. R. Ortaldo
Receptor Glycosylation Regulates Ly-49 Binding to MHC Class I
J. Immunol., October 15, 2003; 171(8): 4235 - 4242.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. T. Silver, K. J. Lavender, D.-E. Gong, B. Hazes, and K. P. Kane
Allelic Variation in the Ectodomain of the Inhibitory Ly-49G2 Receptor Alters Its Specificity for Allogeneic and Xenogeneic Ligands
J. Immunol., November 1, 2002; 169(9): 4752 - 4760.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. W. McVicar, R. Winkler-Pickett, L. S. Taylor, A. Makrigiannis, M. Bennett, S. K. Anderson, and J. R. Ortaldo
Aberrant DAP12 Signaling in the 129 Strain of Mice: Implications for the Analysis of Gene-Targeted Mice
J. Immunol., August 15, 2002; 169(4): 1721 - 1728.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. H. Lian, M. Maeda, S. Lohwasser, M. Delcommenne, T. Nakano, R. E. Vance, D. H. Raulet, and F. Takei
Orderly and Nonstochastic Acquisition of CD94/NKG2 Receptors by Developing NK Cells Derived from Embryonic Stem Cells In Vitro
J. Immunol., May 15, 2002; 168(10): 4980 - 4987.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Saleh, A. P. Makrigiannis, D. L. Hodge, and S. K. Anderson
Identification of a Novel Ly49 Promoter That Is Active in Bone Marrow and Fetal Thymus
J. Immunol., May 15, 2002; 168(10): 5163 - 5169.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Sundback, A. Achour, J. Michaelsson, H. Lindstrom, and K. Karre
NK Cell Inhibitory Receptor Ly-49C Residues Involved in MHC Class I Binding
J. Immunol., January 15, 2002; 168(2): 793 - 800.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Makrigiannis, A. P.
Right arrow Articles by Anderson, S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Makrigiannis, A. P.
Right arrow Articles by Anderson, S. K.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Substance via MeSH


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS